Announcements

Removal of Component(s) – DICE

August 7, 2023

LifeSci Biotechnology Clinical Trials Index

Effective at the market close on Tuesday, August 8, 2023, DICE will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights.

On June 20, 2023, DICE Therapeutics announced that it would be acquired by Eli Lilly for $48.00/share in cash.